Antonio Pesqueira

Dr. Antonio Pesqueira

Technology, Iscte – Instituto Universitário de Lisboa, Lisbon, Lisboa, Portugal
+1
orcid
AI Algorithms - Healthcare Systems

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2019 in Journal of Medical Systems
Verified
Journal Article
Closed access
Maria José SousaMaria José Sousa
Maria José Sousa
Antonio PesqueiraAntonio Pesqueira
Antonio Pesqueira
CLCarlos Lemos
Carlos Lemos
MSMiguel Sousa
Miguel Sousa
Alvaro RochaAlvaro Rocha
Alvaro Rocha

7 January 2021 in Journal of Medical Systems
Verified
Journal Article
Closed access
PDF file
Manuel Luís Au-Yong-OliveiraManuel Luís Au-Yong-Oliveira
Manuel Luís Au-Yong-Oliveira
Antonio PesqueiraAntonio Pesqueira
Antonio Pesqueira
Maria José SousaMaria José Sousa
Maria José Sousa
FMFrancesca Dal Mas
Francesca Dal Mas
MSMohammad Soliman
Mohammad Soliman

9 October 2020 in Journal of Medical Systems
Verified
Journal Article
Open access
PDF file
Antonio PesqueiraAntonio Pesqueira
Antonio Pesqueira
Maria José SousaMaria José Sousa
Maria José Sousa
ÁRÁlvaro Rocha
Álvaro Rocha
Big Data technology is one of the most promising organizational processes within the Healthcare and Pharmaceutical industry and crucial for any company that wants to preserve the competitive advantage in the market, where most of the organizational structures are already struggling with the right skills and knowledge to fully support existing business needs for storing and processing and even analyzing information. This paper aims to examine the extent to which new Big Data technology and data-related processes are developing different professionals skills and competencies within the Healthcare and Pharmaceutical industries, and creating sustainable development in addressing critical organizational challenges in recruiting, retaining, and discover professional skills that can fully support the advances and exponential growth of Big Data technology benefits. This research paper also highlights the significant aspects of Big Data in professional technical and process oriented skills development, and the influence it has on organizational business processes including how various internal functions will need to adapt to new circumstances with renewed competency and skills development programs for departments that are strongly connected to the business and analytical needs. We conducted a focus group with twenty-five industry based professionals’ ranges from analysts to executive directors to better assess the necessary knowledge to answer the proposed research questions: (1) which professional skills can big data influence in employee development and (2) how can organizations adapt their employee skills to big data. Regarding the key research limitations/implications most of the article and research was built on the foundation of the literature review and the performed focus group. The conceptual recommendations and observations presented provide solid empirical evidence but should be subjected to more comprehensive, large-scale empirical testing and validation. It’s recommended for future research a more extensive sample of companies, organizations, and interviewees. Studying a broader set of similar research questions in more homogeneous organizations could provide deeper insights into the process, governance, and stakeholder dimensions of Big Data within specific contexts. Therefore this study contributes to explore in-depth and systematically to what extent Big Data technology and processes are currently influencing the healthcare and pharmaceuticals industries where to the best of the authors’ knowledge, it is the first focus group dealing with the presented research questions.

27 May 2021 in TEM Journal
Verified
Journal Article
Open access
Maria José SousaMaria José Sousa
Maria José Sousa
FMFrancesca Dal Mas
Francesca Dal Mas
Antonio PesqueiraAntonio Pesqueira
Antonio Pesqueira
CLCarlos Lemos
Carlos Lemos
JVJuan Manuel Verde
Juan Manuel Verde
LCLorenzo Cobianchi
Lorenzo Cobianchi
The main goal of this article is to understand the potential learning applications based on AI technologies for health higher education students. We employed a Systematic Literature Review, contributing to explore to what extent AI technologies are currently influencing the Health learning processes in higher education and the skills developed during the learning path. The intent is to contribute to a more profound understanding of learning contexts, methodologies, technologies, and pedagogical processes with the application of AI technologies. The literature emphasizes that AI can be used to potentiate the learning process and the learning outcomes, especially in laboratory classes, and such contexts are still largely unstudied. To fulfil this gap, some practical applications based on AI technologies applied to health higher education studies were identified, highlighting AI's innovations and possible opportunities for health higher education.

6 March 2024 in Software Quality Journal
Verified
Journal Article
Open access
PDF file
Antonio PesqueiraAntonio Pesqueira
Antonio Pesqueira
Maria José SousaMaria José Sousa
Maria José Sousa
Achieving the United Nations’ Sustainable Development Goals (SDGs) requires environmental, social, and governance (ESG) programs in the pharmaceutical industry. Using the Millennium Development Goals, the 2030 agenda aims to transform European Union companies toward sustainability. In pharmaceuticals, in particular, ESG programs come with complexities such as employee skills, corporate goals, and management expectations. Managing these programs effectively requires advanced technologies such as big data analytics (BDA) and dynamic capabilities (DC). In this study, DC theory is used to develop an architecture for managing ESG criteria, focusing on provenance, traceability, and availability. BDA’s role in ESG programs is explored, along with its use cases and benefits, and how DC drives success in ESG implementation. The study examined five pharmaceutical companies in Germany, Portugal, and Switzerland, all consulting the same firm for BDA systems, to identify the characteristics of effective BDA implementation. The research explores how BDA and DC jointly enhance ESG efforts, the essential skills needed, and how DC aids in real-time decision-making in BDA projects aligned with ESG standards. It highlights the BDA system’s accuracy and effectiveness in managing ESG programs, with DC as a pivotal facilitator. Findings reveal BDA’s value in operational efficiency and aligning business models with ESG goals, underscoring the need for diverse skills in BDA implementation and DC’s importance in integrating various managerial capacities into effective strategies. The study promotes a dynamic, data-driven approach in the pharmaceutical industry for managing complex ESG initiatives. It stresses continuous learning, adaptation, and integrating technological advances with ethical business practices. The research concludes by emphasizing BDA and DC’s vital roles in advocating ethical, socially responsible, and environmentally sustainable practices in the pharmaceutical sector, marrying technology with ethical business strategies.

19 October 2023 in WSEAS TRANSACTIONS ON BIOLOGY AND BIOMEDICINE
Verified
Journal Article
Closed access
Antonio PesqueiraAntonio Pesqueira
Antonio Pesqueira
Maria José SousaMaria José Sousa
Maria José Sousa
RPRúben Pereira
Rúben Pereira
The healthcare sector, characterized by its intricate network of stakeholders and rigorous regulatory demands, presents distinct challenges for the integration of Blockchain Technology (BT). Recent focus has shifted towards harnessing Individual Dynamic Capabilities (IDC) to secure a competitive edge. This approach aims to cultivate novel organizational competencies that generate value, ultimately benefiting all stakeholders in the healthcare system during the adoption of emerging technologies. This study delves into the significance of IDC in the seamless integration of BT within hospital infrastructures. The aim is to evaluate whether IDC is instrumental in the triumphant execution of BT initiatives in these settings, propelling innovation, safeguarding data authenticity, and cultivating trust among the involved parties. A systematic literature review (SLR) served as the foundational methodology to address the research objectives. The SLR involved a comprehensive search of databases to identify relevant literature, followed by an in-depth evaluation of the articles that were found. Through this process, the researchers were able to identify and assess the value of IDC in BT initiatives, as well as identify any potential risks associated with its use. Additionally, insights were gleaned regarding the impact of IDC, extrapolated from theoretical frameworks, and contextualized within the realm of hospital BT management. The findings revealed existing synergies between certain IDC and BT solutions, conferring both strategic and operational superiority by aligning BT with intricate demands. The research further underscored the transformative potential of BT across various healthcare facets, ranging from patient documentation to financial transactions. This research can pave the way for subsequent investigations into the interplay between IDC and BT.